| Literature DB >> 27771352 |
Ezia Guatteo1, Francesca Romana Rizzo2, Mauro Federici3, Alberto Cordella4, Ada Ledonne5, Laura Latini6, Annalisa Nobili7, Maria Teresa Viscomi8, Filippo Biamonte9, Kerstin K Landrock10, Alessandro Martini11, Daniela Aversa12, Chiara Schepisi13, Marcello D'Amelio14, Nicola Berretta15, Nicola B Mercuri16.
Abstract
The presence of α-synuclein (α-syn) in Lewy bodies and Lewy neurites is an important characteristic of the neurodegenerative processes of substantia nigra pars compacta (SNpc) dopaminergic (DAergic) neurons in Parkinson's disease (PD) and other synucleinopathies. Here we report that Berlin-Druckrey rats carrying a spontaneous mutation in the 3' untranslated region of α-syn mRNA (m/m rats) display a marked accumulation of α-syn in the mesencephalic area, striatum and frontal cortex, accompanied to severe dysfunctions in the dorsolateral striatum. Despite a small reduction in the number of SNpc and ventral tegmental area DAergic cells, the surviving dopaminergic neurons of the m/m rats do not show clear-cut alterations of the spontaneous and evoked firing activity, DA responses and somatic amphetamine-induced firing inhibition. Interestingly, mutant DAergic neurons display diminished whole-cell Ih conductance and a reduced frequency of spontaneous excitatory synaptic currents. By contrast, m/m rats show a severe impairment of DA and glutamate release in the dorsolateral striatum, as revealed by amperometric measure of DA currents and by electrophysiological recordings of glutamatergic synaptic events in striatal medium spiny neurons. These functional impairments are paralleled by a decreased expression of the DA transporter and VGluT1 proteins in the same area. Thus, together with α-syn overload in the mesencephalic region, striatum and frontal cortex, the main functional alterations occur in the DAergic and glutamatergic terminals in the dorsal striatum of the m/m rats.Entities:
Keywords: Amperometry; DAergic terminals; Dopaminergic neurons; Dorsal striatum; Electrophysiology; Glutamatergic terminals; Lewy bodies dementia; Mutated rats; Parkinson's disease; Substantia nigra; Synaptic release; α-synuclein
Mesh:
Substances:
Year: 2016 PMID: 27771352 DOI: 10.1016/j.expneurol.2016.10.009
Source DB: PubMed Journal: Exp Neurol ISSN: 0014-4886 Impact factor: 5.330